Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations

HERCULES, Calif. -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025. Mehta will lead Bio-Rad's global commercial strategy and execution, succeeding Mike Crowley, who is [...]

Danaher, IGI, CZI Unite for CRISPR Breakthroughs

Sadik Kassim, Danaher CTO for Genomic Medicines and Vanessa Almendro, Danaher Head of Science & Technology Innovation discuss how the work developing a ‘CRISPR Cookbook’ will support the new Center for Pediatric CRISPR Cures. Danaher is proud to provide the essential manufacturing infrastructure for the new Center for Pediatric CRISPR Cures, launched by the Chan Zuckerberg Initiative and [...]

Thermo Fisher Scientific’s Chief Financial Officer, Stephen Williamson, to Retire in Early 2026

Jim Meyer to Become Chief Financial Officer, Effective March 1, 2026 WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Stephen Williamson, senior vice president and chief financial officer (CFO), has decided to retire from the company, effective March 31, 2026. The company’s board of directors [...]

Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations

SEATTLE -- Pluristyx, a leading provider of induced pluripotent stem cell (iPSC) technologies and proprietary gene editing solutions, today announced the successful close of its most recent round of funding led by BioLife Solutions, the global leader in cryopreservation technologies and systems that support cell and gene therapy (CGT) manufacturing, and BroadOak Capital Partners, a [...]

Malvern Panalytical Joins IPAC-RS as an Associate Member: Advancing Aerosol Science and Regulatory Standards

Malvern Panalytical is proud to announce it is now an Associate Member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) – an association that advances the science and regulatory standards of orally inhaled and nasal drug products (OINDPs) through collaboration, research, and development. This strategic partnership underpins Malvern Panalytical’s commitment to innovation [...]

Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations

eattle, Washington – Pluristyx, a leading provider of induced pluripotent stem cell (iPSC) technologies and proprietary gene editing solutions, today announced the successful close of its most recent round of funding led by BioLife Solutions, the global leader in cryopreservation technologies and systems that support cell and gene therapy (CGT) manufacturing, and BroadOak Capital Partners, [...]

Spear Bio Launches Next Generation Ultrasensitive Immunoassay Solution SPEAR UltraDetect™ to Transform Neurodegenerative Disease Research

WOBURN, Mass. -- Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, today announced the commercial launch of its SPEAR UltraDetect™ immunoassay solution. It delivers unparalleled sensitivity, specificity, precision, and scalability for robust biomarker measurement. The initial launch includes four assays, targeting key neurology biomarkers: phosphorylated tau 231 (pTau231), phosphorylated tau 217 (pTau217), glial [...]

MilliporeSigma and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration

Strengthens 90-year legacy of partnership between MilliporeSigma and WashU to accelerate scientific progress Strategic academic-industry alliance aims to build robust Research & Development talent pipeline Reinforces Mill ST. LOUIS — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has signed a non-binding Memorandum of [...]

Molecular Instruments® Continues RNA Imaging Leadership with Next-Generation miRNA/siRNA Detection and Clinical-Grade Ready-to-Use Kits

Molecular Instruments® Continues RNA Imaging Leadership with Next-Generation miRNA/siRNA Detection and Clinical-Grade Ready-to-Use Kits Molecular Instruments® (MI), the inventor of the HCR™ platform, today announced key enhancements to its HCR™ Gold and HCR™ Pro product lines. These upgrades include next-generation chemistry for high-specificity detection of small RNA targets—including microRNAs (miRNAs) and small interfering RNAs (siRNAs)—and [...]

Canada-UK Collaboration Developing AI-powered Bioreactors to Revolutionise Biopharmaceutical Manufacturing

Canada and United Kingdom – An international initiative will transform biologics and drug manufacturing through AI-driven multiplatform integration. The AI-optimised BALANCE (Bioreactor Automation for Learning and Adaptive Networked Control of Experiments) platform will leverage Nicoya’s real-time sensing and control systems, integrated with automation from Labman Automation, bioreactor technologies from CPI, and AI development by Basetwo to make bioprocessing smarter, more efficient, and [...]

Access IBO on Knowledge Center